Microt Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$7.97M
- Investors
-
12
Microt General Information
Description
Developer of ophthalmic and regenerative medical technology designed to support eye health and address optic nerve and skin-related conditions. The company offers research-driven therapeutic products for glaucoma, optic nerve degeneration, and sensitive skin care around the eyes, enabling healthcare professionals and patients to manage eye-related conditions with targeted treatment support.
Contact Information
Website
www.microtinc.comCorporate Office
- Room 157, Basement 4, 81 Ilwon-ro
- Ilwon-dong, Cancer Center, Gangnam-gu
- Seoul, 06351
- South Korea
Corporate Office
- Room 157, Basement 4, 81 Ilwon-ro
- Ilwon-dong, Cancer Center, Gangnam-gu
- Seoul, 06351
- South Korea
Microt Timeline
Microt Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series B) | 31-Jul-2025 | $7.97M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 01-Jan-2024 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Microt Patents
Microt Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4781957-A1 | Aqueous drainage implant structure providing improved fixation and efficient removal of core for preventing hypotony | Pending | 22-Jan-2025 | ||
| US-20260207380-A1 | Aqueous drainage implant structure providing improved fixation and efficient removal of core for preventing hypotony | Pending | 22-Jan-2025 | ||
| JP-2026114885-A | An ophthalmic implant device with optimized inner diameter of the tube and core diameter, and a method for maintaining a patient's intraocular pressure using the same. | Pending | 26-Dec-2024 | ||
| EP-4768000-A1 | Implant device for eye disease with optimized inner diameter of tube and diameter of ripcord and method for maintaining intraocular pressure of subject using the same | Pending | 26-Dec-2024 | ||
| US-20260183146-A1 | Implant device for eye disease with optimized inner diameter of tube and diameter of ripcord and method for maintaining intraocular pressure of subject using the same | Pending | 26-Dec-2024 | A61F9/00781 |
Microt Signals
Microt Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Comes Investment | Venture Capital | Minority | ||
| Horizon Investment | Venture Capital | Minority | ||
| ID Ventures (South Korea) | Venture Capital | Minority | ||
| Industrial Bank of Korea | PE/Buyout | Minority | ||
| Samsung Medical Center | Corporation | Minority |
Microt FAQs
-
When was Microt founded?
Microt was founded in 2019.
-
Where is Microt headquartered?
Microt is headquartered in Seoul, South Korea.
-
What is the size of Microt?
Microt has 27 total employees.
-
What industry is Microt in?
Microt’s primary industry is Surgical Devices.
-
Is Microt a private or public company?
Microt is a Private company.
-
What is Microt’s current revenue?
The current revenue for Microt is .
-
How much funding has Microt raised over time?
Microt has raised $13.7M.
-
Who are Microt’s investors?
Comes Investment, Horizon Investment, ID Ventures (South Korea), Industrial Bank of Korea, and Samsung Medical Center are 5 of 12 investors who have invested in Microt.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process